# OnCo record paper-lehmann-tnbc-subtype-multiomics-nat-commun-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lehmann-tnbc-subtype-multiomics-nat-commun-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lehmann-tnbc-subtype-multiomics-nat-commun-2021" ;
  schema:name "Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes"@en ;
  schema:description "Mesenchymal triple-negative tumours hide from the immune system by switching off the machinery that displays tumour proteins to T cells; a drug class that blocks the PRC2 epigenetic complex switched it back on in mice and made chemotherapy work better."@en ;
  schema:url <https://onco.cc/key-papers/paper-lehmann-tnbc-subtype-multiomics-nat-commun-2021/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41467-021-26502-6>, <https://pubmed.ncbi.nlm.nih.gov/34725325/> ;
  schema:sameAs <https://doi.org/10.1038/s41467-021-26502-6> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Lehmann BD, Colaprico A, Silva TC, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:targets <https://onco.cc/targets/ezh2/>, <https://onco.cc/targets/pdl1/> ;
  onco:institutions <https://onco.cc/institutions/vanderbilt-ingram/> ;
  onco:pathways <https://onco.cc/pathways/antigen-presentation-immunoediting/>, <https://onco.cc/pathways/emt/>, <https://onco.cc/pathways/epigenetic-reprogramming/> ;
  onco:journals <https://onco.cc/journals/nature-communications/> .